Bone Cancer Supportive Care Protocol
Primary Stack
Core supplements with strongest evidenceSupports bone health and immune function; deficiency common in cancer patients; may influence outcomes
Supports remaining bone health; often needed with bisphosphonate therapy
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsAnti-inflammatory; may help maintain muscle mass; supports quality of life during treatment
Supporting Studies (1)
Maintains muscle mass; supports healing; prevents cachexia during treatment
Supporting Studies (1)
May reduce mucositis from chemotherapy; supports gut integrity and immune function
Supporting Studies (1)
Reduces chemotherapy-induced nausea when combined with antiemetics
Supporting Studies (1)
Antioxidant; supports immune function and wound healing; deficiency common in cancer
Supporting Studies (1)
Supports immune function and wound healing; may help with taste changes from treatment
Supporting Studies (1)
Supports gut health during treatment; may reduce antibiotic-related diarrhea
Supporting Studies (1)
May improve sleep; some evidence for quality of life during cancer treatment
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Bone cancer includes primary bone cancers (osteosarcoma, Ewing sarcoma, chondrosarcoma) that start in bone, and metastatic bone disease where cancer from elsewhere (breast, prostate, lung) spreads to bones. Treatment typically involves surgery, chemotherapy, and/or radiation depending on the type and stage.
CRITICAL: Cancer treatment must be directed by your oncology team. This protocol is for SUPPORTIVE CARE ONLY and should be discussed with your oncologist before starting any supplements.
IMPORTANT CONSIDERATIONS:
* Vitamin D and Calcium support bone health. Bisphosphonates (Zometa, Aredia) are often prescribed to protect bones and typically require vitamin D and calcium supplementation.
* Omega-3 Fatty Acids and Protein help maintain muscle mass and fight cachexia (cancer-related wasting).
* Glutamine may reduce mouth sores (mucositis) from chemotherapy - a common and painful side effect.
* Ginger can help with chemotherapy-induced nausea when used alongside prescribed antiemetics.
* Probiotics may help with gut health during treatment but should be avoided if your immune system is severely suppressed.
Expected timeline: Supportive supplements help manage treatment side effects and maintain quality of life. Cancer treatment timelines vary by type and stage. Work closely with your oncology team throughout.
Clinical Perspective
Bone Cancer: Primary bone tumors (rare): osteosarcoma (most common primary, teens/young adults), Ewing sarcoma (children/teens), chondrosarcoma (adults), giant cell tumor. Metastatic bone disease (common): breast, prostate, lung, kidney, thyroid. Presentation: bone pain (worse at night), pathological fractures, spinal cord compression (emergency). Treatment: multimodal - surgery (limb-sparing or amputation), neoadjuvant/adjuvant chemotherapy (osteosarcoma, Ewing), radiation, bone-targeted agents (bisphosphonates, denosumab).
CRITICAL: Oncology team directs all treatment. Supplements are SUPPORTIVE only. Always disclose supplements to oncology team - potential interactions with chemotherapy, radiation, and coagulation. Avoid high-dose antioxidants during active treatment (controversial - may protect cancer cells). Supportive care focuses on: maintaining nutrition, managing side effects, bone protection, quality of life.
* Vitamin D (B-grade): Bone health; immune function. Systematic review: cancer (PMID: 28122805). Meta-analysis: outcomes (PMID: 27427447). 2000-4000 IU daily. Essential with bisphosphonates.
* Calcium (B-grade): Bone protection. Guidelines: (PMID: 26840937). 1000-1200mg daily. Required with bisphosphonates.
* Omega-3 Fatty Acids (B-grade): Cachexia; inflammation. Systematic review: (PMID: 27840029). 2-4g EPA+DHA daily.
* Protein (B-grade): Muscle maintenance. Review: (PMID: 29025082). 1.2-1.5g/kg daily.
* Glutamine (B-grade): Mucositis reduction. Meta-analysis: (PMID: 27363823). 10-30g daily during chemo.
* Ginger (B-grade): CINV. Meta-analysis: (PMID: 23612703). 1-2g daily pre-chemo.
* Vitamin C (C-grade): Immune; healing. Review: (PMID: 27840029). 500-1000mg daily. Avoid mega-doses.
* Zinc (C-grade): Immune; taste. Review: (PMID: 24580542). 15-30mg daily.
* Probiotics (C-grade): Gut health. Systematic review: (PMID: 28969438). 10-20 billion CFU. CONTRAINDICATED if severely neutropenic.
* Melatonin (C-grade): Sleep; QoL. Meta-analysis: (PMID: 24830450). 3-20mg at bedtime.
Assessment targets: Pain scores, functional status (ECOG), nutritional status (weight, albumin), bone markers (if metastatic), imaging response, quality of life measures, treatment-related toxicity grades.
Protocol notes: Bisphosphonates: zoledronic acid (Zometa) or denosumab (Xgeva) standard for bone metastases; reduce skeletal events; require vitamin D/calcium; monitor renal function; ONJ risk with dental procedures. Osteosarcoma: high-dose methotrexate regimens - specific nutrition considerations; leucovorin rescue timing. Ewing sarcoma: intensive chemotherapy - significant mucositis risk; glutamine may help. Spinal cord compression: oncologic emergency - steroids, radiation/surgery within 24-48 hours. Pathological fracture risk: prophylactic fixation may be indicated; activity modification. Pain management: multimodal; radiation effective for bone pain; may need opioids. Radiation-induced nausea: may benefit from ginger + antiemetics. Surgical nutrition: protein needs increased; wound healing support. Limb-sparing surgery: physical therapy essential; functional outcomes generally good. Survivorship: long-term bone health monitoring; late effects of treatment; cardiotoxicity monitoring if anthracyclines used. Clinical trials: consider enrollment for novel therapies; immunotherapy showing promise for some bone cancers.